Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
Mar. 31, 2021	Mar. 31, 2020
Intangible assets
Amortization of intangible assets	$ 47	$ 36
Sales and Marketing Expense
Intangible assets
Royalty fees included in sales and marketing expense	$ 641	$ 492
License agreements
Intangible assets
Notice period for termination of license agreements	60 days
Minimum royalty of agreements	$ 13
Milestone fee upon receiving a Phase II Small Business Innovation Research	15
Milestone fee upon FDA approval	2
Milestone fee upon first commercial use of certain licensed technology	25
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products	$ 10
Minimum \| License agreements
Intangible assets
Amortization period of intangible assets	17 years
Royalty fees range under the license agreements	1.00%
Maximum \| License agreements
Intangible assets
Amortization period of intangible assets	20 years
Royalty fees range under the license agreements	3.00%
Royalty stack cap for royalties paid to more than one licensor for sales of the same product	3.75%
Maximum \| Patents
Intangible assets
Amortization period of intangible assets	20 years

Represents the amount of milestone payment due if Axogen receives FDA approval of its Avance Nerve Graft.

No definition available.

Name:	axgn_MilestonePaymentContingentUponFDApproval
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of milestone payment due upon first commercial use of certain licensed technology to provide services to manufacture products for third parties.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponFirstCommercialUseOfCertainLicensedTechnology
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of milestone payment due upon first use to manufacture products that utilize certain technology that is not currently incorporated into AxoGen products.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponFirstUseToManufactureProductsUtilizingCertainTechnology
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the amount of milestone payment due if the reporting entity receives a grant under one of the grants specified in the license agreement.

+ References

No definition available.

+ Details

Name:	axgn_MilestonePaymentContingentUponReceiptOfGrant
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Minimum quarterly royalty required under the terms of one of the reporting entity's licensing arrangements.

+ References

No definition available.

+ Details

Name:	axgn_MinimumRoyaltyOfLicenseAgreement
Namespace Prefix:	axgn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Notice period for termination of license agreements.

+ References

No definition available.

+ Details

Name:	axgn_NoticePeriodForTerminationOfLicenseAgreements
Namespace Prefix:	axgn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The maximum percentage of royalty which may be paid for the sale of the same product, pursuant to a capping arrangement in the license agreements.

+ References

No definition available.

+ Details

Name:	axgn_PercentageOfCappingRoyaltiesForMultipleRoyaltyPaymentsToLicensors
Namespace Prefix:	axgn_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalty fees percentage under license agreements.

+ References

No definition available.

+ Details

Name:	axgn_RoyaltyFeesPercentageUnderLicenseAgreements
Namespace Prefix:	axgn_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

+ Details

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 926
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: